Innovative Surface Treatment in the Electronics Industry
STEINHAGEN, Germany, Feb. 20, 2025 /PRNewswire/ -- Plasmatreat, a leading company in…
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
MANAMA, Kingdom of Bahrain, Feb. 16, 2025 (GLOBE NEWSWIRE) -- The Bahrain…
Volta Medical Artificial Intelligence-guided Cardiac Ablation Procedure Improves Treatment of Atrial Fibrillation
February 14, 2025 05:30 ET | Source: Volta Medical AI-Guided Cardiac Ablation…
Press Release Biocartis NV: Biocartis announces new data on early CAR-T vector load assessment with Idylla presented at ASTCT: A Potential Breakthrough in LBCL Treatment Monitoring
PRESS RELEASE - 14/02/2025, 09:30 CET Biocartis announces new data on early…
NKGen Biotech Announces Publication of Phase 1 Troculeucel Clinical Trial Results for the Treatment of Alzheimers Disease
February 13, 2025 08:00 ET | Source: NKGen Biotech The results from…
Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
New Patent expands patent estate covering Adial’s unique molecular genetic approach to…
The Largest Insurance Provider in Massachusetts Publishes Positive Reimbursement Policy for the Nerivio REN Wearable for Acute and Preventive Treatment of Migraine
BRIDGEWATER, N.J. and NETANYA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Theranica,…
Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers.
LONDON, MUNICH and NEW DELHI, Feb. 3, 2025 /PRNewswire/ -- Datar Cancer Genetics…
Ellington Financial Inc. Announces the Income Tax Treatment of its 2024 Distributions
OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Financial Inc. (NYSE: EFC) (the "Company") today announced…
Ellington Credit Company Announces the Income Tax Treatment of its 2024 Distributions
OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Credit Company (NYSE: EARN) (the "Company") today announced…